Amdocs Limited (DOX) Key Metrics
DOX valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $6.27B
- Enterprise value
- $6.98B
- P/E (TTM)
- 14.3 10-yr median 18.7
- Forward P/E
- 7.1
- PEG ratio
- 0.79
- Price / sales
- 1.3 10-yr median 2.2
- Price / book
- 1.9 10-yr median 2.7
- EV / EBITDA
- 8.4 10-yr median 11.5
- Dividend yield
- 3.80% $2.28 a year
- Beta
- 0.45
DOX key metrics, FY2016–FY2025
Fiscal year ended September 30, 2025 · U.S. dollarsDOX valuation Price multiples at each fiscal year-end price.
DOX returns How much profit the business earns on the capital it uses.
DOX per-share figures Results divided by the shares outstanding at year-end.
DOX financial health Debt, liquidity and how easily interest is covered.
DOX efficiency & capital use Working capital cycle and where the cash goes.
DOX valuation history
DOX returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
DOX debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
DOX cash returned to shareholders
DOX price vs earnings per share
DOX key metrics
FY2016–FY2025| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $9.17B | $9.97B | $10.01B | $9.68B | $9.69B | $7.65B | $9.07B | $9.48B | $9.48B | $8.75B |
| Enterprise value | $9.67B | $10.24B | $10.08B | $9.69B | $9.60B | $7.70B | $9.33B | $8.99B | $8.88B | $7.85B |
| P/E ratio | 16.2 | 20.2 | 18.5 | 17.6 | 14.1 | 15.4 | 18.9 | 26.8 | 21.7 | 21.4 |
| Price / sales | 2.0 | 2.0 | 2.0 | 2.1 | 2.3 | 1.8 | 2.2 | 2.4 | 2.5 | 2.4 |
| Price / book | 2.7 | 2.9 | 2.8 | 2.8 | 2.7 | 2.1 | 2.6 | 2.7 | 2.7 | 2.5 |
| Price / free cash flow | 14.2 | 16.1 | 14.3 | 18.3 | 13.5 | 16.9 | 17.2 | 29.1 | 18.9 | 17.8 |
| Price / operating cash flow | 12.2 | 13.8 | 12.2 | 12.8 | 10.5 | 11.6 | 13.8 | 17.0 | 14.9 | 14.1 |
| EV / sales | 2.1 | 2.0 | 2.1 | 2.1 | 2.2 | 1.8 | 2.3 | 2.3 | 2.3 | 2.1 |
| EV / EBITDA | 10.4 | 12.5 | 11.8 | 10.9 | 9.2 | 9.7 | 12.0 | 14.1 | 12.2 | 11.2 |
| EV / free cash flow | 15.0 | 16.6 | 14.4 | 18.3 | 13.4 | 17.0 | 17.7 | 27.6 | 17.7 | 16.0 |
| Earnings yield | 6.2% | 4.9% | 5.4% | 5.7% | 7.1% | 6.5% | 5.3% | 3.7% | 4.6% | 4.7% |
| Free cash flow yield | 7.0% | 6.2% | 7.0% | 5.5% | 7.4% | 5.9% | 5.8% | 3.4% | 5.3% | 5.6% |
| Dividend yield | 2.4% | 2.1% | 2.0% | 1.9% | 1.8% | 2.1% | 1.6% | 1.4% | 1.3% | 1.2% |
| Shareholder yield (dividends + buybacks) | 8.5% | 7.8% | 6.9% | 7.2% | 8.9% | 6.9% | 6.0% | 5.8% | 4.9% | 6.0% |
| Share price at fiscal year-end | $82.05 | $87.48 | $84.49 | $79.45 | $75.71 | $57.41 | $66.11 | $65.98 | $64.32 | $57.85 |
| Per share | ||||||||||
| Revenue per share | $40.56 | $43.92 | $41.25 | $37.55 | $33.51 | $31.29 | $29.79 | $27.66 | $26.23 | $24.60 |
| Earnings per share | $5.05 | $4.33 | $4.56 | $4.51 | $5.38 | $3.74 | $3.50 | $2.47 | $2.96 | $2.71 |
| Operating cash flow per share | $6.70 | $6.36 | $6.94 | $6.21 | $7.23 | $4.94 | $4.79 | $3.88 | $4.31 | $4.10 |
| Free cash flow per share | $5.77 | $5.43 | $5.89 | $4.34 | $5.59 | $3.40 | $3.85 | $2.27 | $3.41 | $3.24 |
| Cash per share | $2.91 | $4.51 | $6.27 | $6.71 | $7.55 | $7.38 | $3.44 | $3.61 | $6.64 | $7.25 |
| Book value per share | $30.69 | $30.34 | $29.74 | $28.86 | $28.07 | $27.19 | $25.52 | $24.00 | $24.24 | $22.84 |
| Tangible book value per share | $3.42 | $3.96 | $5.01 | $5.55 | $5.56 | $5.61 | $6.07 | $5.14 | $7.97 | $6.35 |
| Dividends per share | $2.01 | $1.86 | $1.68 | $1.53 | $1.39 | $1.23 | $1.08 | $0.93 | $0.82 | $0.72 |
| Capex per share | $0.93 | $0.93 | $1.05 | $1.86 | $1.64 | $1.54 | $0.93 | $1.61 | $0.90 | $0.86 |
| Debt per share | $7.40 | $6.93 | $6.81 | $6.78 | $6.89 | $7.75 | $5.34 | $0.19 | $2.54 | $1.32 |
| Shares outstanding | 111.7M | 114.0M | 118.5M | 121.9M | 128.0M | 133.2M | 137.2M | 143.7M | 147.4M | 151.2M |
| Change in shares outstanding | −1.9% | −3.8% | −2.8% | −4.8% | −4.0% | −2.9% | −4.5% | −2.5% | −2.5% | −3.6% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 16.4% | 14.1% | 15.4% | 15.5% | 19.1% | 14.0% | 13.8% | 10.1% | 12.4% | 11.9% |
| Return on invested capital (ROIC) | 17.6% | 14.4% | 15.7% | 16.0% | 14.1% | 13.7% | 14.3% | 12.2% | 15.9% | 16.9% |
| Return on assets (ROA) | 8.9% | 7.7% | 8.4% | 8.5% | 10.7% | 8.6% | 9.0% | 6.7% | 8.2% | 7.7% |
| Return on tangible assets | 17.6% | 14.6% | 15.5% | 15.5% | 19.0% | 14.4% | 18.3% | 13.4% | 15.2% | 14.4% |
| Free cash flow margin | 14.2% | 12.4% | 14.3% | 11.6% | 16.7% | 10.9% | 12.9% | 8.2% | 13.0% | 13.2% |
| Income quality (OCF / net income) | 1.33 | 1.47 | 1.52 | 1.38 | 1.34 | 1.32 | 1.37 | 1.57 | 1.46 | 1.52 |
| Financial health | ||||||||||
| Total debt | $826.4M | $789.7M | $807.3M | $826.8M | $881.2M | $1.03B | $732.7M | $27.8M | $375.2M | $200.0M |
| Cash & short-term investments | $325.0M | $514.3M | $742.5M | $818.0M | $965.6M | $983.9M | $471.6M | $519.2M | $979.6M | $1.10B |
| Net debt | $501.4M | $275.4M | $64.8M | $8.9M | −$84.4M | $49.3M | $261.1M | −$491.4M | −$604.4M | −$895.7M |
| Debt / equity | 0.24 | 0.23 | 0.23 | 0.24 | 0.25 | 0.29 | 0.21 | 0.01 | 0.10 | 0.06 |
| Debt / assets | 0.13 | 0.12 | 0.13 | 0.13 | 0.14 | 0.16 | 0.14 | 0.01 | 0.07 | 0.04 |
| Net debt / EBITDA | 0.54 | 0.34 | 0.08 | 0.01 | −0.08 | 0.06 | 0.34 | −0.77 | −0.83 | −1.28 |
| Current ratio | 1.17 | 1.20 | 1.41 | 1.60 | 1.59 | 1.71 | 1.39 | 1.33 | 1.75 | 1.54 |
| Quick ratio | 1.17 | 1.20 | 1.41 | 1.60 | 1.59 | 1.71 | 1.39 | 1.33 | 1.75 | 1.54 |
| Interest coverage | 19.4 | 18.0 | 28.3 | 39.3 | 28.1 | 57.0 | 145.7 | 155.0 | 323.3 | 289.8 |
| Working capital | $233.3M | $300.3M | $558.3M | $750.5M | $763.6M | $858.4M | $467.6M | $425.8M | $875.5M | $734.4M |
| Invested capital | $3.93B | $3.73B | $3.59B | $3.53B | $3.51B | $3.67B | $3.76B | $2.96B | $2.97B | $2.56B |
| Tangible asset value | $423.7M | $493.5M | $636.4M | $719.1M | $753.5M | $790.2M | $874.5M | $781.9M | $1.18B | $960.4M |
| Net current asset value | −$1.19B | −$1.12B | −$947.1M | −$827.0M | −$809.1M | −$601.9M | −$74.8M | −$135.1M | $343.2M | $222.6M |
| Graham number | $59.07 | $54.35 | $55.26 | $54.11 | $58.29 | $47.81 | $44.80 | $36.49 | $40.20 | $37.31 |
| Graham net-net per share | −$15.68 | −$14.05 | −$11.88 | −$10.68 | −$9.85 | −$7.86 | −$3.92 | −$4.23 | −$0.52 | −$1.11 |
| Capital allocation | ||||||||||
| Dividends paid | $224.4M | $212.0M | $199.5M | $186.1M | $177.5M | $164.1M | $147.6M | $134.3M | $121.5M | $109.3M |
| Share buybacks (net) | $551.3M | $563.1M | $489.5M | $508.5M | $680.0M | $360.9M | $398.1M | $419.2M | $340.6M | $413.4M |
| Dividend payout ratio | 39.7% | 43.0% | 36.9% | 33.9% | 25.8% | 33.0% | 30.8% | 37.9% | 27.8% | 26.7% |
| Dividends + buybacks / free cash flow | 120.2% | 125.2% | 98.7% | 131.2% | 119.9% | 116.0% | 103.3% | 169.7% | 91.9% | 106.6% |
| Capex / revenue | 2.3% | 2.1% | 2.5% | 5.0% | 4.9% | 4.9% | 3.1% | 5.8% | 3.4% | 3.5% |
| Capex / operating cash flow | 13.9% | 14.6% | 15.1% | 30.0% | 22.7% | 31.2% | 19.5% | 41.5% | 21.0% | 21.0% |
| Capex / depreciation | 0.53 | 0.55 | 0.64 | 1.01 | 1.01 | 1.04 | 0.62 | 1.09 | 0.62 | 0.61 |
| Stock-based compensation / revenue | 2.3% | 2.1% | 1.8% | 1.6% | 1.3% | 1.0% | 0.9% | 1.2% | 1.2% | 1.1% |
| R&D / revenue | 7.5% | 7.2% | 7.7% | 7.8% | 7.3% | 6.8% | 6.7% | 7.0% | 6.7% | 6.8% |
| SG&A / revenue | 11.2% | 11.4% | 11.7% | 11.5% | 11.4% | 11.0% | 12.1% | 12.1% | 12.2% | 12.5% |
| Efficiency | ||||||||||
| Days sales outstanding | 79.1 | 71.9 | 70.6 | 72.3 | 73.5 | 80.9 | 87.5 | 84.3 | 79.5 | 75.3 |
| Days of inventory on hand | — | — | — | 0.0 | — | — | — | — | — | — |
| Days payables outstanding | 43.0 | 33.7 | 24.7 | 15.8 | 15.0 | 19.0 | 25.5 | 88.2 | 87.1 | 18.8 |
| Cash conversion cycle (days) | 36.1 | 38.3 | 45.9 | 56.5 | 58.5 | 62.0 | 62.0 | -3.9 | -7.6 | 56.4 |
| Receivables turnover | 4.62 | 5.07 | 5.17 | 5.05 | 4.96 | 4.51 | 4.17 | 4.33 | 4.59 | 4.85 |
| Payables turnover | 8.49 | 10.85 | 14.77 | 23.14 | 24.30 | 19.23 | 14.29 | 4.14 | 4.19 | 19.37 |
| Inventory turnover | — | — | — | 2,957,547,000.00 | — | — | — | — | — | — |
| Asset turnover | 0.72 | 0.78 | 0.76 | 0.71 | 0.67 | 0.72 | 0.77 | 0.75 | 0.73 | 0.70 |
| Average receivables | $982.1M | $986.4M | $945.6M | $906.8M | $863.9M | $924.4M | $979.7M | $918.3M | $841.8M | $766.7M |
| Average payables | $338.6M | $299.6M | $213.9M | $127.8M | $115.7M | $143.3M | $185.6M | $627.3M | $598.3M | $124.3M |
| Average inventory | — | — | — | $1 | — | — | — | — | — | — |
| Intangibles / total assets | 48.8% | 47.1% | 45.6% | 44.5% | 44.3% | 45.3% | 50.4% | 50.7% | 45.4% | 46.8% |
Computed from DOX's annual financial statements (latest annual report filed December 15, 2025) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
DOX valuation and financial ratios
At the end of fiscal 2025 (September 30, 2025), Amdocs traded at 16.2 times earnings, against a 10-year median of 18.7. Based on the latest twelve months, the trailing P/E is 14.3 and the forward P/E is 7.1. Amdocs earned a return on equity of 16.4% and a return on invested capital of 17.6% in fiscal 2025. It ended the year with $826.4 million of debt and $325.0 million in cash and short-term investments, net debt of $501.4 million. It returned $775.7 million to shareholders: $224.4 million in dividends and $551.3 million in share buybacks, 120% of free cash flow. The share count fell 26.1% from 151.2M to 111.7M over 9 years.
See the DOX income statement, the DOX chart for price history, or the DOX stock overview for the latest quote and news.
DOX key metrics FAQ
What is Amdocs's P/E ratio?
Amdocs's trailing P/E ratio is 14.3 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 7.1. At the end of fiscal 2025 it was 16.2, compared with a 10-year median of 18.7.
What is Amdocs's EV/EBITDA?
Amdocs's enterprise value was 10.4 times EBITDA at the end of fiscal 2025 (enterprise value $9.7 billion, EBITDA $927.1 million); the current EV/EBITDA is 8.4.
What is Amdocs's return on equity?
Amdocs's return on equity (ROE) was 16.4% in fiscal 2025: net income of $564.7 million on average shareholders' equity of $3.4 billion.
What is Amdocs's ROIC?
Amdocs's return on invested capital was 17.6% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Amdocs have?
Amdocs had total debt of $826.4 million at the end of fiscal 2025, a debt-to-equity ratio of 0.24 and $501.4 million of net debt (0.54 times EBITDA).
What is Amdocs's dividend yield?
Amdocs's forward dividend yield is 3.80%. Amdocs paid $224.4 million in dividends in fiscal 2025 ($2.01 per share), a payout ratio of 39.7%.
Does Amdocs buy back its shares?
Yes. Amdocs spent $551.3 million on net share repurchases in fiscal 2025 Shares outstanding changed −1.9% over the year, to 111.7M..
What is Amdocs's free cash flow yield?
Amdocs generated $645.1 million of free cash flow in fiscal 2025, a free cash flow yield of 7.0% on its market value at year-end ($9.2 billion).
What is Amdocs's current ratio?
Amdocs's current ratio was 1.17 at the end of fiscal 2025: current assets were 1.17 times current liabilities.